Sweden· SE-20201113000091
Zercepac 60 mg Pulver till koncentrat till infusionsvätska, lösning
A medicinal product containing trastuzumab, registered in Sweden by Accord Healthcare S.L.U..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Trastuzumab
- Manufacturer
- Accord Healthcare S.L.U.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20201113000091
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trastuzumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumZercepac 60 mgAccord Healthcare
- CzechiaZERCEPACAccord Healthcare S.L.U., Barcelona
- SpainZERCEPAC 60 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONAccord Healthcare S.L.U.
- FinlandZercepacAccord Healthcare S.L.U.
- United KingdomZercepac 60mg powder for concentrate for solution for infusion vialsAccord-UK Ltd
- IrelandZercepac 60 mg powder for concentrate for solution for infusionAccord Healthcare S.L.U.
- IcelandZercepacAccord Healthcare S.L.U.
- PolandZercepacAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Dazublys, Herceptin
- Liechtenstein · Dazublys, Herceptin
- Norway · Dazublys, Herceptin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe508ea6-348a-482e-8b03-84874182bfe2 GET /v1/drugs/fe508ea6-348a-482e-8b03-84874182bfe2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20201113000091",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20201113000091",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/zercepac"
}See everything about trastuzumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.